These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2463651)

  • 1. The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.
    Stoessl AJ; Dourish CT; Iversen SD
    Psychopharmacology (Berl); 1988; 95(4):502-6. PubMed ID: 2463651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of the behavioural syndrome induced by the NK-3 tachykinin agonist senktide in rodents: evidence for mediation by endogenous 5-HT.
    Stoessl AJ; Dourish CT; Iversen SD
    Brain Res; 1990 May; 517(1-2):111-6. PubMed ID: 1695859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats.
    Stoessl AJ; Dourish CT; Iversen SD
    Br J Pharmacol; 1988 Jun; 94(2):285-7. PubMed ID: 2456111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouse.
    Stoessl AJ; Dourish CT; Young SC; Williams BJ; Iversen SD; Iversen LL
    Neurosci Lett; 1987 Oct; 80(3):321-6. PubMed ID: 2446214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.
    Yamada K; Furukawa T
    Psychopharmacology (Berl); 1980 Jan; 67(1):39-43. PubMed ID: 6768077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory role on gastric secretion of a central NK-3 tachykinin receptor agonist, senktide.
    Improta G; Broccardo M
    Peptides; 1991; 12(6):1433-4. PubMed ID: 1726124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P and its transglutaminase-synthesized spermine derivative elicit yawning behavior via nitric oxide in rats.
    Mancuso F; Porta R; Calignano A; Di Pierro P; Sommella MG; Esposito C
    Peptides; 2001 Sep; 22(9):1453-7. PubMed ID: 11514028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tachykinin NH2-senktide, a selective neurokinin B receptor agonist, is a very potent inhibitor of salt appetite in the rat.
    Massi M; Polidori C; Gentili L; Perfumi M; de Caro G; Maggi CA
    Neurosci Lett; 1988 Oct; 92(3):341-6. PubMed ID: 2462199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central pressor actions of tachykinin NK-3 receptor in the paraventricular nucleus of the rat hypothalamus.
    Nakayama Y; Takano Y; Saito R; Kamiya H
    Brain Res; 1992 Nov; 595(2):339-42. PubMed ID: 1281741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranigral tachykinin NK3 receptor agonist elicits oral movements in rats.
    Liminga U; Johansson PE; Gunne L
    Pharmacol Biochem Behav; 1991 Mar; 38(3):617-20. PubMed ID: 1712496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system.
    Couture R; Laneuville O; Guimond C; Drapeau G; Regoli D
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):547-57. PubMed ID: 2482449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural effects of selective tachykinin agonists in midbrain dopamine regions.
    Stoessl AJ; Szczutkowski E; Glenn B; Watson I
    Brain Res; 1991 Nov; 565(2):254-62. PubMed ID: 1668812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
    Nordquist RE; Durkin S; Jacquet A; Spooren W
    Eur J Pharmacol; 2008 Dec; 600(1-3):87-92. PubMed ID: 18930726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the central tachykinin receptor subclass involved in substance P-induced cardiovascular and behavioral responses in conscious rats.
    Itoi K; Tschöpe C; Jost N; Culman J; Lebrun C; Stauss B; Unger T
    Eur J Pharmacol; 1992 Sep; 219(3):435-44. PubMed ID: 1385176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra.
    Stoessl AJ; Dourish CT; Iversen SD
    Psychopharmacology (Berl); 1987; 93(3):336-42. PubMed ID: 3124163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic and nicotinic effects on yawning and tongue protruding in the rat.
    Ushijima I; Yamada K; Inoue T; Tokunaga T; Furukawa T; Noda Y
    Pharmacol Biochem Behav; 1984 Aug; 21(2):297-300. PubMed ID: 6541344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation.
    Collins P; Broekkamp CL; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1991; 103(4):503-12. PubMed ID: 1676528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tachykinin NH2-senktide inhibits alcohol intake in alcohol-preferring rats.
    Perfumi M; Polidori C; Pompei PL; De Caro G; Massi M
    Pharmacol Biochem Behav; 1991 Apr; 38(4):881-7. PubMed ID: 1714609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of senktide-induced tail whips.
    Nordquist RE; Ballard TM; Algeyer B; Pauly-Evers M; Ozmen L; Spooren W
    Neuropharmacology; 2010 Jan; 58(1):259-67. PubMed ID: 19540857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat.
    Collins P; Broekkamp CL; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1993; 112(4):428-36. PubMed ID: 7871053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.